A
Anna A. Ivanova
Publications - 7
Citations - 122
Anna A. Ivanova is an academic researcher. The author has contributed to research in topics: Medicine & Pandemic. The author has an hindex of 3, co-authored 5 publications receiving 45 citations.
Papers
More filters
Journal ArticleDOI
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.
Andrey Komissarov,Ksenia R. Safina,Ksenia R. Safina,Sofya K. Garushyants,Artem Fadeev,Mariia Sergeeva,Anna A. Ivanova,Daria Danilenko,Dmitry Lioznov,Olga V. Shneider,Nikita Shvyrev,Vadim Spirin,Dmitry Glyzin,Vladimir Shchur,Georgii A. Bazykin,Georgii A. Bazykin +15 more
TL;DR: In this article, the authors analyzed the emergence of SARS-CoV-2 in Russia in March and April 2020 and found that the sampled viral diversity has originated from at least 67 closely timed introductions into Russia, mostly in late February to early March.
Posted ContentDOI
Genomic epidemiology of the early stages of SARS-CoV-2 outbreak in Russia
Andrey Komissarov,Ksenia R. Safina,Sofya K. Garushyants,Artem Fadeev,Mariia Sergeeva,Anna A. Ivanova,Daria Danilenko,Dmitry Lioznov,Olga V. Shneider,Nikita Shvyrev,Vadim Spirin,Dmitry Glyzin,Vladimir Shchur,Georgii A. Bazykin +13 more
TL;DR: It is estimated that the sampled viral diversity has originated from 67 closely timed introductions into Russia, mostly in late February to early March, suggesting that border closure with China has helped delay establishment of SARS-CoV-2 in Russia.
Posted ContentDOI
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
Oksana V. Stanevich,Evgeniia Alekseeva,M. V. Sergeeva,Artem Fadeev,Kseniya Komissarova,Anna A. Ivanova,Tamara Simakova,Kirill Vasilyev,Anna-Polina Shurygina,Marina Stukova,Ksenia R. Safina,Elena Nabieva,Sofya K. Garushyants,Galya V. Klink,Evgeny A. Bakin,Jullia Zabutova,Anastasia Kholodnaia,Olga Lukina,Irina A. Skorokhod,Viktoria V. Ryabchikova,Nadezhda Medvedeva,Dmitry Lioznov,Daria Danilenko,Dmitriy Chudakov,Andrey Komissarov,Georgii A. Bazykin +25 more
TL;DR: It is suggested that CD8 T cell escape may be an underappreciated contributor to SARS-CoV-2 evolution in humans.
Journal ArticleDOI
Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection
Irina L. Baranovskaya,Mariia Sergeeva,Artem Fadeev,Renata Kadirova,Anna A. Ivanova,Edward Ramsay,Andrey V. Vasin,Andrey V. Vasin +7 more
TL;DR: Growth curve experiments and ELISA data show that, at least in the first viral replication cycle, mutations G123A and A132G affecting RNA structure in the (82–148) NS RNA region influence NS1 protein expression.
Journal ArticleDOI
Long-term dynamics of the levels of anti-SARS-CoV-2 S-protein IgG antibodies in vaccinated individuals
O. M. Drapkina,S. A. Burns,Alexander Y. Gorshkov,Veronika N. Shishkova,L. N. Ryzhakova,O. A. Litinskaya,Anna A. Ivanova,Alina Veretennikova,V.S. Bashnyak,E. Y. Tatarevich +9 more
TL;DR: The data obtained show that the level of anti-SARS-CoV-2 S-protein antibodies 42 days after Gam-COVID-Vac vaccination is significantly higher than after CoviVacvaccine, and an increase in thelevel of IgG in both groups indicates the ability of both vaccines to stimulate the production ofAnti-Sars- CoV antibodies.